Cargando…
Requirements for Proper Immunosuppressive Regimens to Limit Translational Failure of Cardiac Cell Therapy in Preclinical Large Animal Models
Various cell-based therapies are currently investigated in an attempt to tackle the high morbidity and mortality associated with heart failure. The need for these therapies to move towards the clinic is pressing. Therefore, preclinical large animal studies that use non-autologous cells are needed to...
Autores principales: | Demkes, Evelyne J., Rijken, Simone, Szymanski, Mariusz K., Hoefer, Imo E., Sluijter, Joost P. G., de Jager, Saskia C. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892682/ https://www.ncbi.nlm.nih.gov/pubmed/32476086 http://dx.doi.org/10.1007/s12265-020-10035-2 |
Ejemplares similares
-
Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models
por: Demkes, Evelyne J., et al.
Publicado: (2021) -
Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
por: van Ham, Willem B., et al.
Publicado: (2022) -
Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration
por: Peng, Yizhong, et al.
Publicado: (2021) -
NLRP3-Inflammasome Inhibition with IZD334 Does Not Reduce Cardiac Damage in a Pig Model of Myocardial Infarction
por: Silvis, Max J. M., et al.
Publicado: (2022) -
Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease
por: Meeuwsen, John A. L., et al.
Publicado: (2017)